Exact Sciences Accounts Payable

Exact Sciences (EXAS) currently reports a accounts payable of $0 as of December 2025. That compares with $90M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Exact Sciences's accounts payable history and peer comparisons.

Exact Sciences's accounts payable decreased from $90M to $0 — a 100.0% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exact Sciences reported $0 in accounts payable as of December 2025. That compares with $90M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Exact Sciences, and consider following EXAS for alerts when major investors trade the stock.

Exact Sciences is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EXAS with unrelated industries.